These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21862649)

  • 21. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of survival pathways in the degenerating retina of rd10 mice.
    Samardzija M; Wariwoda H; Imsand C; Huber P; Heynen SR; Gubler A; Grimm C
    Exp Eye Res; 2012 Jun; 99():17-26. PubMed ID: 22546314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choroidal neovascularization in the rat induced by adenovirus mediated expression of vascular endothelial growth factor.
    Baffi J; Byrnes G; Chan CC; Csaky KG
    Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3582-9. PubMed ID: 11006256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of VLDLR in the retina and evolution of subretinal neovascularization in the knockout mouse model's retinal angiomatous proliferation.
    Hu W; Jiang A; Liang J; Meng H; Chang B; Gao H; Qiao X
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):407-15. PubMed ID: 18172119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of anti-VEGF treatment on the recovery of the developing retina following oxygen-induced retinopathy.
    Tokunaga CC; Mitton KP; Dailey W; Massoll C; Roumayah K; Guzman E; Tarabishy N; Cheng M; Drenser KA
    Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1884-92. PubMed ID: 24550366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF expression and receptor activation in the choroid during development and in the adult.
    Saint-Geniez M; Maldonado AE; D'Amore PA
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3135-42. PubMed ID: 16799060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo monitoring of VEGF-induced retinal damage in the Kimba mouse model of retinal neovascularization.
    Ali Rahman IS; Li CR; Lai CM; Rakoczy EP
    Curr Eye Res; 2011 Jul; 36(7):654-62. PubMed ID: 21657827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of Fatty Acid Binding Protein 7 (FABP7) in the Murine Retina.
    Su X; Tan QS; Parikh BH; Tan A; Mehta MN; Sia Wey Y; Tun SB; Li LJ; Han XY; Wong TY; Hunziker W; Luu CD; Owada Y; Barathi VA; Zhang SS; Chaurasia SS
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3397-408. PubMed ID: 27367508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential role of tumor necrosis factor (TNF)-alpha receptors in the development of choroidal neovascularization.
    Jasielska M; Semkova I; Shi X; Schmidt K; Karagiannis D; Kokkinou D; Mackiewicz J; Kociok N; Joussen AM
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):3874-83. PubMed ID: 20335614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
    Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Downregulation of vascular endothelial growth factor and integrinbeta3 by endostatin in a mouse model of retinal neovascularization.
    Zhang M; Yang Y; Yan M; Zhang J
    Exp Eye Res; 2006 Jan; 82(1):74-80. PubMed ID: 16198337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and neuroprotective effect of hepatocyte growth factor in retinal ischemia-reperfusion injury.
    Shibuki H; Katai N; Kuroiwa S; Kurokawa T; Arai J; Matsumoto K; Nakamura T; Yoshimura N
    Invest Ophthalmol Vis Sci; 2002 Feb; 43(2):528-36. PubMed ID: 11818401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe retinal degeneration associated with disruption of semaphorin 4A.
    Rice DS; Huang W; Jones HA; Hansen G; Ye GL; Xu N; Wilson EA; Troughton K; Vaddi K; Newton RC; Zambrowicz BP; Sands AT
    Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2767-77. PubMed ID: 15277503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of retinal neovascularization by shRNA targeting HIF-1alpha.
    Xia XB; Xiong SQ; Xu HZ; Jiang J; Li Y
    Curr Eye Res; 2008 Oct; 33(10):892-902. PubMed ID: 18853324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina.
    Cashman SM; Desai A; Ramo K; Kumar-Singh R
    Invest Ophthalmol Vis Sci; 2011 May; 52(6):3436-45. PubMed ID: 21357400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
    Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
    Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced P-selectin in hearts pretreated with fluvastatin: a novel benefit for patients undergoing open heart surgery.
    Berkan O; Katrancioglu N; Ozker E; Ozerdem G; Bakici Z; Yilmaz MB
    Thorac Cardiovasc Surg; 2009 Mar; 57(2):91-5. PubMed ID: 19241310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, fluvastatin, as a novel agent for prophylaxis of renal cancer metastasis.
    Horiguchi A; Sumitomo M; Asakuma J; Asano T; Asano T; Hayakawa M
    Clin Cancer Res; 2004 Dec; 10(24):8648-55. PubMed ID: 15623649
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice.
    Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT
    Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt.
    Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.